Quick Answer
Silence Therapeutics plc reported Total Assets of $131.44 million for fiscal year 2025.
Silence Therapeutics plc Total Assets — Annual History
| Fiscal Year | Total Assets | YoY Change |
|---|---|---|
| 2025 | $131.44M | -35.1% |
| 2024 | $202.63M | +69.6% |
| 2023 | $119.45M | — |
Quarterly Total Assets
| Quarter Ending | Total Assets | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $146.79M | — | -11.2% |
| June 30, 2025 | $165.23M | — | -10.8% |
| March 31, 2025 | $185.30M | — | -8.6% |
| December 31, 2024 | $202.63M | — | — |
- Silence Therapeutics plc showed a decrease of -35.1% in Total Assets compared to the prior fiscal year.
- Over the 2023–2025 period, Silence Therapeutics plc’s total assets has grown by 10.0% (from $119.45 million to $131.44 million).
- The most recent figure is from Silence Therapeutics plc’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 5, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: